Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M285,834Revenue $M74,331Net Margin (%)22.0Z-Score5.2
Enterprise Value $M271,505EPS $5.7Operating Margin %28.2F-Score7
P/E(ttm))18.0Cash Flow Per Share $6.2Pre-tax Margin (%)27.7Higher ROA y-yY
Price/Book4.110-y EBITDA Growth Rate %4.0Quick Ratio2.0Cash flow > EarningsY
Price/Sales4.05-y EBITDA Growth Rate %5.6Current Ratio2.4Lower Leverage y-yN
Price/Cash Flow11.3y-y EBITDA Growth Rate %24.9ROA % (ttm)12.3Higher Current Ratio y-yY
Dividend Yield %2.7Insider Buy (3m)0ROE % (ttm)21.8Less Shares Outstanding y-yY
Payout Ratio %48.0Shares Outstanding M2,780ROI % (ttm)15.4Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJJohn Hussman 2014-12-31 Add1.19%$96.78 - $109.07
($105.37)
$ 102.8-2%Add 8301.89%111,325
JNJJoel Greenblatt 2014-12-31 Add0.66%$96.78 - $109.07
($105.43)
$ 102.8-2%Add 5420.84%790,529
JNJJohn Rogers 2014-12-31 Add0.11%$96.78 - $109.07
($105.37)
$ 102.8-2%Add 17.8%632,132
JNJHOTCHKIS & WILEY 2014-12-31 Sold Out $96.78 - $109.07
($105.37)
$ 102.8-2%Sold Out0
JNJRobert Olstein 2014-12-31 Reduce-0.17%$96.78 - $109.07
($105.37)
$ 102.8-2%Reduce -14.46%71,000
JNJRichard Perry 2014-12-31 Reduce-0.11%$96.78 - $109.07
($105.37)
$ 102.8-2%Reduce -8.67%312,610
JNJRay Dalio 2014-12-31 Reduce-0.02%$96.78 - $109.07
($105.37)
$ 102.8-2%Reduce -23.64%64,293
JNJJoel Greenblatt 2014-09-30 Buy 0.02%$99.82 - $108.64
($103.64)
$ 102.8-1%New holding, 14319 sh.14,319
JNJRay Dalio 2014-09-30 Add0.02%$99.82 - $108.64
($103.64)
$ 102.8-1%Add 27.77%84,193
JNJDodge & Cox 2014-09-30 Add$99.82 - $108.64
($103.64)
$ 102.8-1%Add 21.93%47,095
JNJHOTCHKIS & WILEY 2014-09-30 Reduce-0.53%$99.82 - $108.64
($103.64)
$ 102.8-1%Reduce -99.8%2,862
JNJJames Barrow 2014-09-30 Reduce-0.24%$99.82 - $108.64
($103.64)
$ 102.8-1%Reduce -10.05%15,350,650
JNJYacktman Focused Fund 2014-09-30 Reduce-0.21%$99.82 - $108.64
($103.64)
$ 102.8-1%Reduce -6.06%3,100,000
JNJDonald Yacktman 2014-09-30 Reduce-0.17%$99.82 - $108.64
($103.64)
$ 102.8-1%Reduce -4.36%8,651,258
JNJYacktman Fund 2014-09-30 Reduce-0.13%$99.82 - $108.64
($103.64)
$ 102.8-1%Reduce -3.7%3,900,000
JNJGeorge Soros 2014-09-30 Sold Out -0.04%$99.82 - $108.64
($103.64)
$ 102.8-1%Sold Out0
JNJJohn Rogers 2014-06-30 Add0.2%$96.54 - $105.76
($101.02)
$ 102.82%Add 42.46%522,727
JNJRichard Pzena 2014-06-30 Add0.17%$96.54 - $105.76
($101.02)
$ 102.82%Add 33.12%1,155,666
JNJHOTCHKIS & WILEY 2014-06-30 Reduce-0.89%$96.54 - $105.76
($101.02)
$ 102.82%Reduce -63.73%1,426,614
JNJYacktman Focused Fund 2014-06-30 Reduce-0.51%$96.54 - $105.76
($101.02)
$ 102.82%Reduce -13.16%3,300,000
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
JNJ John Hussman 2014-12-31111,32501.2+8301.89%
JNJ Joel Greenblatt 2014-12-31790,5290.030.67+5420.84%
JNJ John Rogers 2014-12-31632,1320.020.76+17.8%
JNJ James Barrow 2014-12-3115,491,3860.562.2+0.92%
JNJ Michael Price 2014-12-3135,00000.45
JNJ Tom Gayner 2014-12-31574,2000.021.6
JNJ Richard Snow 2014-12-313,27000.01
JNJ Prem Watsa 2014-12-3182,85000.56
JNJ Warren Buffett 2014-12-31327,1000.010.03
JNJ Brian Rogers 2014-12-314,633,0000.171.7
JNJ Yacktman Focused Fund 2014-12-313,100,0000.113.5
JNJ Yacktman Fund 2014-12-313,900,0000.143.5
JNJ Richard Pzena 2014-12-311,183,9660.040.66-0.04%
JNJ Ken Fisher 2014-12-3110,424,6070.372.3-0.21%
JNJ Ruane Cunniff 2014-12-3175,94600.04-0.41%
JNJ Donald Yacktman 2014-12-318,611,3590.313.7-0.46%
JNJ Tweedy Browne 2014-12-314,142,4450.1511.1-0.52%
JNJ PRIMECAP Management 2014-12-3112,143,4330.441.3-0.61%
JNJ Jean-Marie Eveillard 2014-12-311,616,9270.060.41-2.1%
JNJ Dodge & Cox 2014-12-3144,23500-6.07%
JNJ Mario Gabelli 2014-12-31336,9350.010.18-8.03%
JNJ Richard Perry 2014-12-31312,6100.011.4-8.67%
JNJ Robert Olstein 2014-12-3171,00000.91-14.46%
JNJ Ray Dalio 2014-12-3164,29300.05-23.64%
JNJ HOTCHKIS & WILEY 2014-12-31000Sold Out
JNJ Mark Hillman 2013-12-3130,74604.2-0.27%
JNJ Meridian Funds 2013-06-307,88500.03
Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
JOHNSON & JOHNSON10% Owner 2014-12-17Sell8,100$7.621228.22view
JOHNSON & JOHNSON10% Owner 2014-12-12Sell5,000$7.511247.67view
JOHNSON & JOHNSON10% Owner 2014-12-10Sell8,300$7.721211.01view
JOHNSON & JOHNSON10% Owner 2014-12-05Sell15,900$7.761204.25view
JOHNSON & JOHNSON10% Owner 2014-12-01Sell1,200$7.541242.31view
JOHNSON & JOHNSON10% Owner 2014-11-26Sell2,000$7.751205.94view
JOHNSON & JOHNSON10% Owner 2014-11-24Sell9,500$8.141143.37view
JOHNSON & JOHNSON10% Owner 2014-11-12Buy40,000$18462.28view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-6.76view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-5.79view

Press Releases about JNJ :

    Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Investing: Keep It Simple Feb 25 2015 
    All Investing Involves Risk Feb 24 2015 
    Johnson & Johnson Has A Potential Buyer For Its Medical Devices Unit Feb 24 2015 
    test Feb 23 2015 
    possible Feb 22 2015 
    possible Feb 22 2015 
    Johnson & Johnson: Why Investors Should Consider This Stock for Long-Term Gains Feb 22 2015 
    Paul Tudor Jones Is Betting on the SPY, Should You? Feb 20 2015 
    Medtronic Q3 Earnings 2015 Exceeds Market Expectations Feb 19 2015 
    Enphase Energy (ENPH) Record-Breaking Growth, Boston Scientific (BSX) and Johnson & Johnson (JNJ) En Feb 18 2015 


    More From Other Websites
    Biosimilar copies of blockbuster drug launch in major EU markets Feb 25 2015
    Johnson & Johnson Loses Trial Over Risperdal And Male Breasts Feb 24 2015
    Brain-Altering Devices May Supplant Drugs -- And Pharma Is OK With That Feb 24 2015
    JOHNSON & JOHNSON Files SEC form 10-K, Annual Report Feb 24 2015
    J&J settles more defective hip device lawsuits Feb 23 2015
    3 Companies That Could Be Negatively Impacted By Johnson & Johnson Sale Of Cordis Feb 23 2015
    J&J settles more defective hip device lawsuits Feb 23 2015
    [video]'Mad Money' Lightning Round: J&J Must Get Its Game Back Feb 21 2015
    Cramer: This stock is on a run Feb 20 2015
    New conference focused on early-stage funding comes to Houston Feb 20 2015
    Boston Scientific Settles $7.2B J&J Suit for $600M, Stock Up - Analyst Blog Feb 19 2015
    Pharmacyclics Misses on Q4 Earnings, Reiterates 2015 View - Analyst Blog Feb 19 2015
    The Zacks Analyst Blog Highlights: TIAA-CREF Social Choice Equity Retail, Johnson & Johnson, Procter... Feb 19 2015
    Boston Scientific Closes Up 12% Feb 18 2015
    Boston Scientific Soars 11% After Settling Dispute With Johnson & Johnson Feb 18 2015
    Social Responsible Investing Can Be Profitable Too: 2 Funds to Buy - Mutual Fund Commentary Feb 18 2015
    Why Big Pharma Must Cure Its Bad Rap Feb 18 2015
    Sterne Agree Weighs In On Boston Scientific-Johnson & Johnson Litigation Settlement Feb 18 2015
    Stock Futures Show Mild Losses; Boston Scientific Bolts Higher Feb 18 2015
    Boston Scientific (BSX) Stock Higher Today After Johnson & Johnson Suit Settlement Feb 18 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK